Inventor
SNYDER LAWRENCE B
US45 patents
⚠️ This page may combine multiple inventors who share the name “SNYDER LAWRENCE B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
19 patentsUS7659270B2Feb 9, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations98
US7759495B2Jul 20, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO58 citations94
US8642025B2Feb 4, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7906655B2Mar 15, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US7183302B2Feb 27, 2007
Iminothiazolidinones as inhibitors of HCV replication
BRISTOL MYERS SQUIBB CO32 citations89
US9227961B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations84
US8846023B2Sep 30, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US8735398B2May 27, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations83
US6465456B2Oct 15, 2002
Isoxazolinone antibacterial agents
BRISTOL MYERS SQUIBB CO19 citations80
US9018390B2Apr 28, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US8383094B2Feb 26, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US8362020B2Jan 29, 2013
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
USRE49735ENov 28, 2023
Oxazolidinones as modulators of MGLUR5
BRISTOL MYERS SQUIBB CO0 citations60
US6420349B1Jul 16, 2002
Isoxazolinone antibacterial agents
BRISTOL MYERS SQUIBB CO4 citations54
US9758487B2Sep 12, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10287291B2May 14, 2019
Seco-cyclopropapyrroloindole compounds, antibody-drug conjugates thereof, and methods of making and use
BRISTOL MYERS SQUIBB CO0 citations42
ARVINAS OPERATIONS INC
13 patentsUS11236051B2Feb 1, 2022
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC9 citations94
US10844021B2Nov 24, 2020
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC13 citations94
US11952347B2Apr 9, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC3 citations86
US11883393B2Jan 30, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC5 citations86
US12077509B2Sep 3, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC1 citations73
US11964945B2Apr 23, 2024
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC2 citations73
US11191741B2Dec 7, 2021
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC3 citations73
US12427144B2Sep 30, 2025
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC0 citations62
US12312316B2May 27, 2025
Compounds and methods for the targeted degradation of androgen receptor
ARVINAS OPERATIONS INC0 citations62
US12239711B2Mar 4, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations62
US11857519B2Jan 2, 2024
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
ARVINAS OPERATIONS INC0 citations62
US12441708B2Oct 14, 2025
Cereblon ligands and bifunctional compounds comprising the same
ARVINAS OPERATIONS INC0 citations52
US12419960B2Sep 23, 2025
Compounds and methods for the targeted degradation of androgen receptor and associated methods of use
ARVINAS OPERATIONS INC0 citations52
BACHAND CAROL
6 patentsUS8574563B2Nov 5, 2013
Hepatitis C virus inhibitors
BACHAND CAROL18 citations92
US8303944B2Nov 6, 2012
Hepatitis C virus inhibitors
BACHAND CAROL36 citations92
US8147818B2Apr 3, 2012
Hepatitis C virus inhibitors
BACHAND CAROL22 citations92
US8492553B2Jul 23, 2013
Hepatitis C virus inhibitors
BACHAND CAROL11 citations84
US8288562B2Oct 16, 2012
Hepatitis C virus inhibitors
BACHAND CAROL9 citations84
US8093243B2Jan 10, 2012
Hepatitis C virus inhibitors
BACHAND CAROL5 citations62